Aegerion Pharmaceuticals Holdings, Inc.

ABOUT THE CASE

Aegerion Pharmaceuticals Holdings, Inc.

SECTOR: Pharmaceuticals
CONFIRMED DATE: June 2019
ROLE: Financial Advisor to the Official Committee of Unsecured Creditors
Aegerion is a biopharmaceutical company focused on the development and commercialization of rare and orphan drugs for the treatment of generalized lipodystrophy and homozygous familial hypercholesterolemia. Province was retained by the official committee of unsecured creditors to analyze the Debtors go forward business plan and proposed capital structure, conduct a sum-of-the-parts valuation of the company and its business segments, and ensure the proposed plan would become confirmed.
Go Back